Browsing by Author Dzamko, Nicolas

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodiesDzamko, Nicolas; Halliday, Glenda; Bandopadhyay, Rina; Bolliger, Marc; et al, Various; Gysbers, Amanda M.; Takahashi-Fujigasak, Junko; Takao, Masaki; Uchino, Akiko; Van de Berg, Wilma; Wauters, Sandrine; Zhao, Ye; Central Clinical School: Medicine; Central Clinical School: MedicineLRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies, Movement Disorders, vol.32, 3, 2017,pp 423-432
2015Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammationChen, Ew-Jun; Doddareddy, Munikumar; Kassiou, Michael; Kavanagh, Madeline; Munoz, Lenka; Phoa, Athena; Dzamko, Nicolas; Guillemin, Gilles J.; Heng, Benjamin; Not known; School of Medical Sciences: Brain & Mind Research Institute; Medical Imaging and Radiation Sciences; Chemistry; School of Medical Sciences: Pharmacology; School of Medical Sciences: PharmacologyOptimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammation, European Journal of Medicinal Chemistry, vol.95, N/A, 2015,pp 29-34
2017Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathologyDzamko, Nicolas; Halliday, Glenda; Bahar, Anita; Fu, YuHong; Gao, Jianqun; Gysbers, Amanda M.; Perera, G; Shankar, Amrita; Central Clinical School: Medicine; Central Clinical School: MedicineToll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology, Acta Neuropathologica Communications, vol.133, 2, 2017,pp 303-319